The fertility industry: profiting from vulnerability
By Editorial Staff,
The Lancet
| 07. 20. 2024
Image by DrKontogianniIVF from Wikimedia Commons
Despite major advances in securing sexual and reproductive rights globally, one aspect is continually neglected: infertility. Evolving gender norms and financial precariousness have led to delayed childbearing, which increases infertility in both males and females. An estimated one in six people are affected. However, there is insufficient awareness about fertility decline, the risk factors, and viable treatments for infertility. Assisted reproductive technologies (ARTs), particularly in-vitro fertilisation (IVF), help many. Almost 50 years after the birth of the first baby conceived by IVF was reported in The Lancet, this method is used in 9% of births in some high-income countries. Such advances have enabled millions to have children. However, the fertility sector has now spawned an entire industry that risks exacerbating rather than alleviating the psychological toll of infertility and does little to help reduce inequities in access to quality care.
Medical advances have helped increase the effectiveness of IVF. In women aged 35–37 years in the UK, the livebirth rate per embryo transferred increased from 6% in 1991 to 25% in 2019...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...